Related references
Note: Only part of the references are listed.Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure
Michael R. Zile et al.
CIRCULATION-HEART FAILURE (2011)
Tissue Inhibitor of Metalloproteinase-2 Gene Delivery Ameliorates Postinfarction Cardiac Remodeling
Ravi Ramani et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Usefulness of Plasma Tissue Inhibitors of Metalloproteinases as Markers of Prognosis After Acute Myocardial Infarction
Dominic Kelly et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Tissue Inhibitor of Metalloproteinases 3 Regulates Resolution of Inflammation following Acute Lung Injury
Sean E. Gill et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction
Vijay Kandalam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
Anne-Catherine Pouleur et al.
CIRCULATION (2010)
Preventing Adverse Remodeling and Rupture During Healing After Myocardial Infarction in Mice and Humans
Bodh I. Jugdutt
CIRCULATION (2010)
TIMP2 Deficiency Accelerates Adverse Post-Myocardial Infarction Remodeling Because of Enhanced MT1-MMP Activity Despite Lack of MMP2 Activation
Vijay Kandalam et al.
CIRCULATION RESEARCH (2010)
Extracellular matrix fibrotic markers in heart failure
Faiez Zannad et al.
HEART FAILURE REVIEWS (2010)
Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction
Arantxa Gonzalez et al.
HYPERTENSION (2010)
Mice with Tissue Inhibitor of Metalloproteinases 4 (Timp4) Deletion Succumb to Induced Myocardial Infarction but Not to Cardiac Pressure Overload
Ilpo Koskivirta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TIMP3: a physiological regulator of adult myogenesis
Huijie Liu et al.
JOURNAL OF CELL SCIENCE (2010)
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression
Bao Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Extracellular matrix remodeling during the progression of volume overload-induced heart failure
Kirk R. Hutchinson et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'
Davy Vanhoutte et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Extracellular matrix turnover and signaling during cardiac remodeling following MI: Causes and consequences
Rogelio Zamilpa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover
Ramon Martos et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Simultaneous Transforming Growth Factor β-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient Heart
Zamaneh Kassiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Loss of TIMP3 Enhances Interstitial Nephritis and Fibrosis
Zamaneh Kassiri et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Age-related differences in postinfarct left ventricular rupture and remodeling
Yining Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction
Takefumi Takahashi et al.
CIRCULATION JOURNAL (2008)
Matrix Metalloproteinases and Their Tissue Inhibitors in Cardiac Amyloidosis Relationship to Structural, Functional Myocardial Changes and to Light Chain Amyloid Deposition
Andreia Biolo et al.
CIRCULATION-HEART FAILURE (2008)
Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease
Angela Papa et al.
CLINICA CHIMICA ACTA (2008)
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction
Dominic Kelly et al.
EUROPEAN HEART JOURNAL (2008)
Circulating Stromelysin-1 (MMP-3): A novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction
D. Kelly et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
The regulation of matrix metalloproteinases and their inhibitors
Ian A. Clark et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Fragments of extracellular matrix as mediators of inflammation
Tracy L. Adair-Kirk et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Macrophage roles following myocardial infarction
Jessica M. Lambert et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release
Eloy Cuadrado et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Structural determinants of the ADAM inhibition by TIMP-3: Crystal structure of the TACE-N-TIMP-3 complex
Magdalena Wisniewska et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Tissue Inhibitor of Metalloproteinases-4. The road less traveled
Jorge Melendez-Zajgla et al.
MOLECULAR CANCER (2008)
Membrane type 1-matrix metalloproteinase: Substrate diversity in pericellular proteolysis
Maria V. Barbolina et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Role of metalloproteinases in platelet function
Maria Jose Santos-Martinez et al.
THROMBOSIS RESEARCH (2008)
Atrial extracellular matrix remodelling in patients with atrial fibrillation
V. Polyakova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions
Takahisa Takino et al.
CANCER RESEARCH (2007)
TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction
Hai Tian et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Interaction of MT1-MMP and laminin-5γ2 chain correlates with metastasis and invasiveness in human esophageal squamous cell carcinoma
Xiao-Ming Shen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function
Francis G. Spinale
PHYSIOLOGICAL REVIEWS (2007)
Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression
Lamis Hammoud et al.
CARDIOVASCULAR RESEARCH (2007)
Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates neuromuscular junction development via a β1 integrin-mediated mechanism
Gentian Lluri et al.
JOURNAL OF NEUROBIOLOGY (2006)
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction - Relation to left ventricular remodeling
Carson S. Webb et al.
CIRCULATION (2006)
Matrix metalloproteinase-8: Cleavage can be decisive
Philippe Van Lint et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
FOXO1A differentially regulates genes of decidualization
Oscar L. Buzzio et al.
ENDOCRINOLOGY (2006)
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction - Results of the PREMIER (prevention of myocardial infarction early remodeling) trial
Michael P. Hudson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Individual Timp deficiencies differentially impact pro-MMP-2 activation
JL English et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Novel functions of TIMPs in cell signaling
R Chirco et al.
CANCER AND METASTASIS REVIEWS (2006)
Integrins, membrane-type matrix metalloproteinases and ADAMS: Potential implications for cardiac remodeling
AM Manso et al.
CARDIOVASCULAR RESEARCH (2006)
Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation
R Mukherjee et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Cutting edge: Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation
DS Smookler et al.
JOURNAL OF IMMUNOLOGY (2006)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
SA Hunt et al.
CIRCULATION (2005)
Ribo-gnome: The big world of small RNAs
PD Zamore et al.
SCIENCE (2005)
Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart
S Heymans et al.
CIRCULATION (2005)
Combination of tumor necrosis factor-α ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice
Z Kassiri et al.
CIRCULATION RESEARCH (2005)
Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
RE Stroud et al.
JOURNAL OF CARDIAC FAILURE (2005)
TIMP-2: an endogenous inhibitor of angiogenesis
WG Stetler-Stevenson et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts
JD Lovelock et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition
JS Ikonomidis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Expression analysis of the entire MMP and TIMP gene families during mouse tissue development
RK Nuttall et al.
FEBS LETTERS (2004)
Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction
Y Noji et al.
CIRCULATION JOURNAL (2004)
TIMPs as multifacial proteins
E Lambert et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures:: the Framingham heart study
J Sundström et al.
EUROPEAN HEART JOURNAL (2004)
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration
FF Mohammed et al.
NATURE GENETICS (2004)
Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK
J Oh et al.
CANCER RESEARCH (2004)
Transforming growth factor β1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species
WQ Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis
J Fielitz et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
TIMP-3 deficiency leads to dilated cardiomyopathy
PWM Fedak et al.
CIRCULATION (2004)
Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils
A Matsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism
DW Seo et al.
CELL (2003)
Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure
PJR Barton et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2003)
Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury
CJ Schulze et al.
CIRCULATION (2003)
A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
JH Qi et al.
NATURE MEDICINE (2003)
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice
EEJM Creemers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
AH Baker et al.
JOURNAL OF CELL SCIENCE (2002)
TIMP-1 - A marker of left ventricular diastolic dysfunction and fibrosis in hypertension
MM Lindsay et al.
HYPERTENSION (2002)
Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients
J Díez et al.
CIRCULATION (2002)
Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene
DA Young et al.
BIOCHEMICAL JOURNAL (2002)
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats
Y Iwanaga et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Monocyte chemotactic activity in human abdominal aortic aneurysms: Role of elastin degradation peptides and the 67-kD cell surface elastin receptor
KA Hance et al.
JOURNAL OF VASCULAR SURGERY (2002)
Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy
PM Timms et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
M Asakura et al.
NATURE MEDICINE (2002)
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
J Oh et al.
CELL (2001)
Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices
YY Li et al.
CIRCULATION (2001)
Fibrogenic and inflammatory cytokines modulate mRNA expressions of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-3 in type II pneumocytes
Y Hoshino et al.
RESPIRATION (2001)
Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA
MY Çeliker et al.
ONCOGENE (2001)
Integrins and the myocardium
RS Ross et al.
CIRCULATION RESEARCH (2001)
TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5)
M Kashiwagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Differential roles of TIMP-4 and TIMP-2 in Pro-MMP-2 activation by MT1-MMP
S Hernandez-Barrantes et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3
F Loechel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix
WH Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
TIMP-2 is required for efficient activation of proMMP-2 in vivo
ZP Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinases-2
ZD Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction
SH Poulsen et al.
CIRCULATION (2000)
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
YY Li et al.
CARDIOVASCULAR RESEARCH (2000)
Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice
L Roten et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
